{
  "total_facts": 54,
  "average_quality_score": 94.44444444444444,
  "estimated_precision": 1.0,
  "results": [
    {
      "fact": {
        "drug_name": "escitalopram",
        "condition_name": "major depressive disorder",
        "relation": "FIRST_LINE_FOR",
        "outcome": "remission rate",
        "side_effects": [
          "nausea",
          "sexual dysfunction"
        ],
        "effect_size": "42% remission vs 28% placebo, NNT=7",
        "confidence_interval": "95% CI 1.2\u20132.4",
        "source_id": "WJCC",
        "section": "World Journal of Clinical Cases",
        "span": "In an 8\u2011week randomized trial (n=485) in adults with major depressive disorder, escitalopram 10\u201320 mg/day achieved higher remission (42% vs 28% placebo; NNT=7; 95% CI 1.2\u20132.4; p<0.01). Nausea and sexual dysfunction were the most frequent adverse events.",
        "confidence": 1.0,
        "treatment_line": "first",
        "patient_subgroup": null,
        "study_design": "RCT",
        "sample_size": 485,
        "duration": "8 weeks",
        "dose": "10\u201320 mg/day",
        "p_value": 0.001
      },
      "quality_score": 100.0,
      "likely_correct": true,
      "method_results": {
        "heuristic": {
          "quality_score": 100,
          "likely_correct": true,
          "issues": []
        }
      }
    },
    {
      "fact": {
        "drug_name": "sertraline",
        "condition_name": "major depressive disorder",
        "relation": "PREVENTS_RELAPSE_IN",
        "outcome": null,
        "side_effects": [],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "WJCC",
        "section": "World Journal of Clinical Cases",
        "span": "Continuation treatment with sertraline over 6 months reduced relapse rates compared with placebo in patients with major depressive disorder, according to a randomized withdrawal design.",
        "confidence": 0.9,
        "treatment_line": null,
        "patient_subgroup": null,
        "study_design": "RCT",
        "sample_size": 312,
        "duration": "6 months",
        "dose": null,
        "p_value": null
      },
      "quality_score": 100.0,
      "likely_correct": true,
      "method_results": {
        "heuristic": {
          "quality_score": 100,
          "likely_correct": true,
          "issues": []
        }
      }
    },
    {
      "fact": {
        "drug_name": "cognitive behavioral therapy",
        "condition_name": "major depressive disorder",
        "relation": "WELL_TOLERATED_IN",
        "outcome": null,
        "side_effects": [],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "WJCC",
        "section": "World Journal of Clinical Cases",
        "span": "In adolescents with major depressive disorder treated in outpatient settings, cognitive behavioral therapy was generally well tolerated with low discontinuation for adverse events.",
        "confidence": 0.8,
        "treatment_line": null,
        "patient_subgroup": "adolescents",
        "study_design": "observational",
        "sample_size": null,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "quality_score": 100.0,
      "likely_correct": true,
      "method_results": {
        "heuristic": {
          "quality_score": 100,
          "likely_correct": true,
          "issues": []
        }
      }
    },
    {
      "fact": {
        "drug_name": "escitalopram",
        "condition_name": "major depressive disorder",
        "relation": "FIRST_LINE_FOR",
        "outcome": "remission rate",
        "side_effects": [
          "nausea",
          "sexual dysfunction"
        ],
        "effect_size": "42% remission vs 28% placebo, NNT=7",
        "confidence_interval": "95% CI 1.2\u20132.4",
        "source_id": "WJCC",
        "section": "Major depressive disorder: Validated treatments and future challenges",
        "span": "In an 8\u2011week randomized trial (n=485) in adults with major depressive disorder, escitalopram 10\u201320 mg/day achieved higher remission (42% vs 28% placebo; NNT=7; 95% CI 1.2\u20132.4; p<0.01). Nausea and sexual dysfunction were the most frequent adverse events.",
        "confidence": 1.0,
        "treatment_line": "first",
        "patient_subgroup": null,
        "study_design": "RCT",
        "sample_size": 485,
        "duration": "8 weeks",
        "dose": "10\u201320 mg/day",
        "p_value": 0.001
      },
      "quality_score": 100.0,
      "likely_correct": true,
      "method_results": {
        "heuristic": {
          "quality_score": 100,
          "likely_correct": true,
          "issues": []
        }
      }
    },
    {
      "fact": {
        "drug_name": "sertraline",
        "condition_name": "major depressive disorder",
        "relation": "PREVENTS_RELAPSE_IN",
        "outcome": null,
        "side_effects": [],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "WJCC",
        "section": "Major depressive disorder: Validated treatments and future challenges",
        "span": "Continuation treatment with sertraline over 6 months reduced relapse rates compared with placebo in patients with major depressive disorder, according to a randomized withdrawal design.",
        "confidence": 0.9,
        "treatment_line": null,
        "patient_subgroup": null,
        "study_design": "RCT",
        "sample_size": 312,
        "duration": "6 months",
        "dose": null,
        "p_value": null
      },
      "quality_score": 100.0,
      "likely_correct": true,
      "method_results": {
        "heuristic": {
          "quality_score": 100,
          "likely_correct": true,
          "issues": []
        }
      }
    },
    {
      "fact": {
        "drug_name": "cognitive behavioral therapy",
        "condition_name": "major depressive disorder",
        "relation": "WELL_TOLERATED_IN",
        "outcome": null,
        "side_effects": [],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "WJCC",
        "section": "Major depressive disorder: Validated treatments and future challenges",
        "span": "In adolescents with major depressive disorder treated in outpatient settings, cognitive behavioral therapy was generally well tolerated with low discontinuation for adverse events.",
        "confidence": 0.8,
        "treatment_line": null,
        "patient_subgroup": "adolescents",
        "study_design": "observational",
        "sample_size": null,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "quality_score": 100.0,
      "likely_correct": true,
      "method_results": {
        "heuristic": {
          "quality_score": 100,
          "likely_correct": true,
          "issues": []
        }
      }
    },
    {
      "fact": {
        "drug_name": "selective serotonin reuptake inhibitors",
        "condition_name": "depression",
        "relation": "FIRST_LINE_FOR",
        "outcome": null,
        "side_effects": [],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "WJCC",
        "section": "abstract",
        "span": "Pharmacotherapy, especially selective serotonin reuptake inhibitors antidepressants, remains the most frequent option for treating depression during the acute phase.",
        "confidence": 0.9,
        "treatment_line": null,
        "patient_subgroup": null,
        "study_design": null,
        "sample_size": null,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "quality_score": 100.0,
      "likely_correct": true,
      "method_results": {
        "heuristic": {
          "quality_score": 100,
          "likely_correct": true,
          "issues": []
        }
      }
    },
    {
      "fact": {
        "drug_name": "depression-focused psychotherapy",
        "condition_name": "depression",
        "relation": "MAINTENANCE_FOR",
        "outcome": null,
        "side_effects": [],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "WJCC",
        "section": "abstract",
        "span": "Depression-focused psychotherapy is the second most common option for helping patients overcome the acute phase, maintain remission, and prevent relapses.",
        "confidence": 0.8,
        "treatment_line": null,
        "patient_subgroup": null,
        "study_design": null,
        "sample_size": null,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "quality_score": 100.0,
      "likely_correct": true,
      "method_results": {
        "heuristic": {
          "quality_score": 100,
          "likely_correct": true,
          "issues": []
        }
      }
    },
    {
      "fact": {
        "drug_name": "depression-focused psychotherapy",
        "condition_name": "depression",
        "relation": "PREVENTS_RELAPSE_IN",
        "outcome": null,
        "side_effects": [],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "WJCC",
        "section": "abstract",
        "span": "Depression-focused psychotherapy is the second most common option for helping patients overcome the acute phase, maintain remission, and prevent relapses.",
        "confidence": 0.8,
        "treatment_line": null,
        "patient_subgroup": null,
        "study_design": null,
        "sample_size": null,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "quality_score": 100.0,
      "likely_correct": true,
      "method_results": {
        "heuristic": {
          "quality_score": 100,
          "likely_correct": true,
          "issues": []
        }
      }
    },
    {
      "fact": {
        "drug_name": "electroconvulsive therapy",
        "condition_name": "depression",
        "relation": "EFFECTIVE_IN_SUBGROUP",
        "outcome": null,
        "side_effects": [],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "WJCC",
        "section": "abstract",
        "span": "Electroconvulsive therapy is the most effective somatic therapy for depression in some specific situations.",
        "confidence": 0.8,
        "treatment_line": null,
        "patient_subgroup": "specific situations",
        "study_design": null,
        "sample_size": null,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "quality_score": 100.0,
      "likely_correct": true,
      "method_results": {
        "heuristic": {
          "quality_score": 100,
          "likely_correct": true,
          "issues": []
        }
      }
    },
    {
      "fact": {
        "drug_name": "electroconvulsive therapy",
        "condition_name": "major depressive disorder",
        "relation": "TREATS",
        "outcome": null,
        "side_effects": [],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "WJCC",
        "section": "introduction",
        "span": "Acute-phase treatment options include pharmacotherapy, depression-focused psychotherapy, combinations of medications and psychotherapy, and somatic therapies such as electroconvulsive therapy (ECT).",
        "confidence": 0.8,
        "treatment_line": null,
        "patient_subgroup": null,
        "study_design": null,
        "sample_size": null,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "quality_score": 90.0,
      "likely_correct": true,
      "method_results": {
        "heuristic": {
          "quality_score": 90,
          "likely_correct": true,
          "issues": [
            "Condition not explicitly mentioned in span"
          ]
        }
      }
    },
    {
      "fact": {
        "drug_name": "pharmacotherapy",
        "condition_name": "major depressive disorder",
        "relation": "TREATS",
        "outcome": null,
        "side_effects": [],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "WJCC",
        "section": "introduction",
        "span": "Acute-phase treatment options include pharmacotherapy, depression-focused psychotherapy, combinations of medications and psychotherapy, and somatic therapies such as electroconvulsive therapy (ECT).",
        "confidence": 0.8,
        "treatment_line": null,
        "patient_subgroup": null,
        "study_design": null,
        "sample_size": null,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "quality_score": 90.0,
      "likely_correct": true,
      "method_results": {
        "heuristic": {
          "quality_score": 90,
          "likely_correct": true,
          "issues": [
            "Condition not explicitly mentioned in span"
          ]
        }
      }
    },
    {
      "fact": {
        "drug_name": "depression-focused psychotherapy",
        "condition_name": "major depressive disorder",
        "relation": "TREATS",
        "outcome": null,
        "side_effects": [],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "WJCC",
        "section": "introduction",
        "span": "Acute-phase treatment options include pharmacotherapy, depression-focused psychotherapy, combinations of medications and psychotherapy, and somatic therapies such as electroconvulsive therapy (ECT).",
        "confidence": 0.8,
        "treatment_line": null,
        "patient_subgroup": null,
        "study_design": null,
        "sample_size": null,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "quality_score": 90.0,
      "likely_correct": true,
      "method_results": {
        "heuristic": {
          "quality_score": 90,
          "likely_correct": true,
          "issues": [
            "Condition not explicitly mentioned in span"
          ]
        }
      }
    },
    {
      "fact": {
        "drug_name": "combinations of medications and psychotherapy",
        "condition_name": "major depressive disorder",
        "relation": "TREATS",
        "outcome": null,
        "side_effects": [],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "WJCC",
        "section": "introduction",
        "span": "Acute-phase treatment options include pharmacotherapy, depression-focused psychotherapy, combinations of medications and psychotherapy, and somatic therapies such as electroconvulsive therapy (ECT).",
        "confidence": 0.8,
        "treatment_line": null,
        "patient_subgroup": null,
        "study_design": null,
        "sample_size": null,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "quality_score": 90.0,
      "likely_correct": true,
      "method_results": {
        "heuristic": {
          "quality_score": 90,
          "likely_correct": true,
          "issues": [
            "Condition not explicitly mentioned in span"
          ]
        }
      }
    },
    {
      "fact": {
        "drug_name": "selective serotonin reuptake inhibitors",
        "condition_name": "depression",
        "relation": "FIRST_LINE_FOR",
        "outcome": null,
        "side_effects": [],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "WJCC",
        "section": "PHARMACOTHERAPY",
        "span": "While selective serotonin reuptake inhibitors (SSRIs) remain the gold-standard treatment for depression, new antidepressants are always being developed and tested.",
        "confidence": 0.9,
        "treatment_line": null,
        "patient_subgroup": null,
        "study_design": null,
        "sample_size": null,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "quality_score": 100.0,
      "likely_correct": true,
      "method_results": {
        "heuristic": {
          "quality_score": 100,
          "likely_correct": true,
          "issues": []
        }
      }
    },
    {
      "fact": {
        "drug_name": "TCAs",
        "condition_name": "major depressive disorder",
        "relation": "EQUIVALENT_TO",
        "outcome": null,
        "side_effects": [],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "WJCC",
        "section": "TCAs",
        "span": "TCAs-such as amitriptyline, nortriptyline, protriptyline, imipramine, desipramine, doxepin, and trimipramine-are about as effective as other classes of antidepressants-including SSRIs, SNRIs, and MAOIs-in treating major depression.",
        "confidence": 0.9,
        "treatment_line": null,
        "patient_subgroup": null,
        "study_design": "comparative",
        "sample_size": null,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "quality_score": 80.0,
      "likely_correct": true,
      "method_results": {
        "heuristic": {
          "quality_score": 80,
          "likely_correct": true,
          "issues": [
            "Span doesn't contain typical EQUIVALENT_TO language"
          ]
        }
      }
    },
    {
      "fact": {
        "drug_name": "TCAs",
        "condition_name": "major depressive disorder",
        "relation": "SUPERIOR_TO",
        "outcome": null,
        "side_effects": [],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "WJCC",
        "section": "TCAs",
        "span": "However, some TCAs can be more effective than SSRIs when used to treat hospitalized patients. This efficacy can be explained by the superiority of TCAs over SSRIs for patients with severe major depressive disorder (MDD) symptoms who require hospitalization.",
        "confidence": 0.8,
        "treatment_line": null,
        "patient_subgroup": "hospitalized patients with severe symptoms",
        "study_design": null,
        "sample_size": null,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "quality_score": 100.0,
      "likely_correct": true,
      "method_results": {
        "heuristic": {
          "quality_score": 100,
          "likely_correct": true,
          "issues": []
        }
      }
    },
    {
      "fact": {
        "drug_name": "fluoxetine",
        "condition_name": "depression",
        "relation": "EQUIVALENT_TO",
        "outcome": null,
        "side_effects": [],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "WJCC",
        "section": "SSRIs",
        "span": "In December 1987, a series of clinical studies confirmed that an SSRI called fluoxetine was as effective as TCAs for treating depression while causing fewer adverse effects.",
        "confidence": 0.9,
        "treatment_line": null,
        "patient_subgroup": null,
        "study_design": "clinical studies",
        "sample_size": null,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "quality_score": 80.0,
      "likely_correct": true,
      "method_results": {
        "heuristic": {
          "quality_score": 80,
          "likely_correct": true,
          "issues": [
            "Span doesn't contain typical EQUIVALENT_TO language"
          ]
        }
      }
    },
    {
      "fact": {
        "drug_name": "SSRIs",
        "condition_name": "major depressive disorder",
        "relation": "FIRST_LINE_FOR",
        "outcome": null,
        "side_effects": [],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "WJCC",
        "section": "SSRIs",
        "span": "Therefore, most guidelines currently recommend SSRIs as the first-line treatment for patients with major depression.",
        "confidence": 0.9,
        "treatment_line": null,
        "patient_subgroup": null,
        "study_design": "systematic reviews and meta-analyses",
        "sample_size": null,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "quality_score": 100.0,
      "likely_correct": true,
      "method_results": {
        "heuristic": {
          "quality_score": 100,
          "likely_correct": true,
          "issues": []
        }
      }
    },
    {
      "fact": {
        "drug_name": "SSRIs",
        "condition_name": "depression",
        "relation": "EQUIVALENT_TO",
        "outcome": null,
        "side_effects": [],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "WJCC",
        "section": "SSRIs",
        "span": "In most systematic reviews and meta-analyses, SSRIs have demonstrated comparable efficacy to TCAs.",
        "confidence": 0.9,
        "treatment_line": null,
        "patient_subgroup": null,
        "study_design": "systematic reviews and meta-analyses",
        "sample_size": null,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "quality_score": 90.0,
      "likely_correct": true,
      "method_results": {
        "heuristic": {
          "quality_score": 90,
          "likely_correct": true,
          "issues": [
            "Condition not explicitly mentioned in span"
          ]
        }
      }
    },
    {
      "fact": {
        "drug_name": "SSRIs",
        "condition_name": "depression",
        "relation": "WELL_TOLERATED_IN",
        "outcome": null,
        "side_effects": [
          "sexual dysfunction",
          "nausea",
          "loss of appetite",
          "irritability",
          "anxiety",
          "insomnia",
          "headaches"
        ],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "WJCC",
        "section": "SSRIs",
        "span": "Currently available SSRIs include fluoxetine, sertraline, paroxetine, fluvoxamine, citalopram, and escitalopram. They have elicited different tolerance rates and side effects-mostly sexual and digestive (nausea and loss of appetite), as well as irritability, anxiety, insomnia, and headaches. Nevertheless, SSRIs have a good tolerability profile.",
        "confidence": 0.8,
        "treatment_line": null,
        "patient_subgroup": null,
        "study_design": null,
        "sample_size": null,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "quality_score": 90.0,
      "likely_correct": true,
      "method_results": {
        "heuristic": {
          "quality_score": 90,
          "likely_correct": true,
          "issues": [
            "Condition not explicitly mentioned in span"
          ]
        }
      }
    },
    {
      "fact": {
        "drug_name": "venlafaxine",
        "condition_name": "depression",
        "relation": "EQUIVALENT_TO",
        "outcome": null,
        "side_effects": [],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "WJCC",
        "section": "Norepinephrine reuptake inhibitors",
        "span": "Also, venlafaxine's efficacy is comparable to that of TCAs.",
        "confidence": 0.9,
        "treatment_line": null,
        "patient_subgroup": null,
        "study_design": null,
        "sample_size": null,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "quality_score": 90.0,
      "likely_correct": true,
      "method_results": {
        "heuristic": {
          "quality_score": 90,
          "likely_correct": true,
          "issues": [
            "Condition not explicitly mentioned in span"
          ]
        }
      }
    },
    {
      "fact": {
        "drug_name": "reboxetine",
        "condition_name": "depression",
        "relation": "ASSOCIATED_WITH_SE",
        "outcome": null,
        "side_effects": [
          "poor tolerance"
        ],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "WJCC",
        "section": "Norepinephrine reuptake inhibitors",
        "span": "However, these findings could be due to the relatively poor tolerance of reboxetine.",
        "confidence": 0.8,
        "treatment_line": null,
        "patient_subgroup": null,
        "study_design": null,
        "sample_size": null,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "quality_score": 90.0,
      "likely_correct": true,
      "method_results": {
        "heuristic": {
          "quality_score": 90,
          "likely_correct": true,
          "issues": [
            "Condition not explicitly mentioned in span"
          ]
        }
      }
    },
    {
      "fact": {
        "drug_name": "trazodone",
        "condition_name": "major depressive disorder",
        "relation": "TREATS",
        "outcome": null,
        "side_effects": [],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "WJCC",
        "section": "Other antidepressants",
        "span": "Trazodone is the oldest medication of the so-called 'other antidepressants' group that is still in wide use. It has been shown to be an effective antidepressant in placebo-controlled research.",
        "confidence": 0.9,
        "treatment_line": null,
        "patient_subgroup": null,
        "study_design": null,
        "sample_size": null,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "quality_score": 90.0,
      "likely_correct": true,
      "method_results": {
        "heuristic": {
          "quality_score": 90,
          "likely_correct": true,
          "issues": [
            "Condition not explicitly mentioned in span"
          ]
        }
      }
    },
    {
      "fact": {
        "drug_name": "nefazodone",
        "condition_name": "major depressive disorder",
        "relation": "EQUIVALENT_TO",
        "outcome": null,
        "side_effects": [],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "WJCC",
        "section": "Other antidepressants",
        "span": "Nefazodone's structure is analogous to that of trazodone, though it has different pharmacological properties. Its efficacy and overall tolerability are comparable to those of SSRIs, as indicated by comparative trials.",
        "confidence": 0.9,
        "treatment_line": null,
        "patient_subgroup": null,
        "study_design": null,
        "sample_size": null,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "quality_score": 90.0,
      "likely_correct": true,
      "method_results": {
        "heuristic": {
          "quality_score": 90,
          "likely_correct": true,
          "issues": [
            "Condition not explicitly mentioned in span"
          ]
        }
      }
    },
    {
      "fact": {
        "drug_name": "bupropion",
        "condition_name": "major depressive disorder",
        "relation": "EQUIVALENT_TO",
        "outcome": null,
        "side_effects": [],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "WJCC",
        "section": "Other antidepressants",
        "span": "However, for individuals with low to moderate levels of anxiety, the efficacy of bupropion in treating MDD is comparable to that of SSRIs.",
        "confidence": 0.9,
        "treatment_line": null,
        "patient_subgroup": null,
        "study_design": null,
        "sample_size": null,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "quality_score": 90.0,
      "likely_correct": true,
      "method_results": {
        "heuristic": {
          "quality_score": 90,
          "likely_correct": true,
          "issues": [
            "Condition not explicitly mentioned in span"
          ]
        }
      }
    },
    {
      "fact": {
        "drug_name": "bupropion",
        "condition_name": "major depressive disorder",
        "relation": "IMPROVES",
        "outcome": null,
        "side_effects": [],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "WJCC",
        "section": "Other antidepressants",
        "span": "In addition, bupropion is more likely than some SSRIs to improve symptoms of fatigue and sleepiness.",
        "confidence": 0.8,
        "treatment_line": null,
        "patient_subgroup": null,
        "study_design": null,
        "sample_size": null,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "quality_score": 90.0,
      "likely_correct": true,
      "method_results": {
        "heuristic": {
          "quality_score": 90,
          "likely_correct": true,
          "issues": [
            "Condition not explicitly mentioned in span"
          ]
        }
      }
    },
    {
      "fact": {
        "drug_name": "imipramine",
        "condition_name": "major depressive disorder",
        "relation": "EFFECTIVE_IN_SUBGROUP",
        "outcome": null,
        "side_effects": [
          "cardiovascular toxicity",
          "anticholinergic side effects"
        ],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "WJCC",
        "section": "Perspectives",
        "span": "Imipramine, a tricyclic antidepressant, demonstrated efficacy in patients with more severe symptoms of major depressive disorder. However, it is associated with cardiovascular toxicity and anticholinergic side effects, with a risk of lethal toxicity from overdoses.",
        "confidence": 0.8,
        "treatment_line": null,
        "patient_subgroup": null,
        "study_design": null,
        "sample_size": null,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "quality_score": 100.0,
      "likely_correct": true,
      "method_results": {
        "heuristic": {
          "quality_score": 100,
          "likely_correct": true,
          "issues": []
        }
      }
    },
    {
      "fact": {
        "drug_name": "desipramine",
        "condition_name": "major depressive disorder",
        "relation": "EFFECTIVE_IN_SUBGROUP",
        "outcome": null,
        "side_effects": [
          "cardiovascular toxicity",
          "anticholinergic side effects"
        ],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "WJCC",
        "section": "Perspectives",
        "span": "Desipramine, another tricyclic antidepressant, is effective in patients with more severe symptoms of major depressive disorder. It carries risks of cardiovascular toxicity and anticholinergic side effects, and there is a risk of lethal toxicity from overdoses.",
        "confidence": 0.8,
        "treatment_line": null,
        "patient_subgroup": null,
        "study_design": null,
        "sample_size": null,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "quality_score": 100.0,
      "likely_correct": true,
      "method_results": {
        "heuristic": {
          "quality_score": 100,
          "likely_correct": true,
          "issues": []
        }
      }
    },
    {
      "fact": {
        "drug_name": "nortriptyline",
        "condition_name": "major depressive disorder",
        "relation": "EFFECTIVE_IN_SUBGROUP",
        "outcome": null,
        "side_effects": [
          "cardiovascular toxicity",
          "anticholinergic side effects"
        ],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "WJCC",
        "section": "Perspectives",
        "span": "Nortriptyline is effective in patients with more severe symptoms of major depressive disorder. It is associated with cardiovascular toxicity and anticholinergic side effects, with a risk of lethal toxicity from overdoses.",
        "confidence": 0.8,
        "treatment_line": null,
        "patient_subgroup": null,
        "study_design": null,
        "sample_size": null,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "quality_score": 100.0,
      "likely_correct": true,
      "method_results": {
        "heuristic": {
          "quality_score": 100,
          "likely_correct": true,
          "issues": []
        }
      }
    },
    {
      "fact": {
        "drug_name": "amitriptyline",
        "condition_name": "major depressive disorder",
        "relation": "EFFECTIVE_IN_SUBGROUP",
        "outcome": null,
        "side_effects": [
          "cardiovascular toxicity",
          "anticholinergic side effects"
        ],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "WJCC",
        "section": "Perspectives",
        "span": "Amitriptyline has shown efficacy in patients with more severe symptoms of major depressive disorder. It is linked to cardiovascular toxicity and anticholinergic side effects, with a risk of lethal toxicity from overdoses.",
        "confidence": 0.8,
        "treatment_line": null,
        "patient_subgroup": null,
        "study_design": null,
        "sample_size": null,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "quality_score": 100.0,
      "likely_correct": true,
      "method_results": {
        "heuristic": {
          "quality_score": 100,
          "likely_correct": true,
          "issues": []
        }
      }
    },
    {
      "fact": {
        "drug_name": "psychotherapy",
        "condition_name": "depression",
        "relation": "TREATS",
        "outcome": null,
        "side_effects": [],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "WJCC",
        "section": "PSYCHOTHERAPY",
        "span": "Psychotherapy for patients with depression strengthens the therapeutic alliance and enables the patient to monitor their mood, improve their functioning, understand their symptoms better, and master the practical tools they need to cope with stressful events.",
        "confidence": 0.8,
        "treatment_line": null,
        "patient_subgroup": null,
        "study_design": null,
        "sample_size": null,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "quality_score": 100.0,
      "likely_correct": true,
      "method_results": {
        "heuristic": {
          "quality_score": 100,
          "likely_correct": true,
          "issues": []
        }
      }
    },
    {
      "fact": {
        "drug_name": "cognitive-behavioral therapy",
        "condition_name": "major depressive disorder",
        "relation": "FIRST_LINE_FOR",
        "outcome": null,
        "side_effects": [],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "WJCC",
        "section": "Overview of psychotherapy in depression",
        "span": "Depression-focused psychotherapy is typically considered the initial treatment method for mild to moderate MDD. Based on significant clinical evidence, two specific psychotherapeutic methods are recommended: Cognitive-behavioral therapy (CBT) and interpersonal therapy (IPT).",
        "confidence": 0.9,
        "treatment_line": null,
        "patient_subgroup": null,
        "study_design": null,
        "sample_size": null,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "quality_score": 90.0,
      "likely_correct": true,
      "method_results": {
        "heuristic": {
          "quality_score": 90,
          "likely_correct": true,
          "issues": [
            "Condition not explicitly mentioned in span"
          ]
        }
      }
    },
    {
      "fact": {
        "drug_name": "interpersonal therapy",
        "condition_name": "major depressive disorder",
        "relation": "FIRST_LINE_FOR",
        "outcome": null,
        "side_effects": [],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "WJCC",
        "section": "Overview of psychotherapy in depression",
        "span": "Depression-focused psychotherapy is typically considered the initial treatment method for mild to moderate MDD. Based on significant clinical evidence, two specific psychotherapeutic methods are recommended: Cognitive-behavioral therapy (CBT) and interpersonal therapy (IPT).",
        "confidence": 0.9,
        "treatment_line": null,
        "patient_subgroup": null,
        "study_design": null,
        "sample_size": null,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "quality_score": 90.0,
      "likely_correct": true,
      "method_results": {
        "heuristic": {
          "quality_score": 90,
          "likely_correct": true,
          "issues": [
            "Condition not explicitly mentioned in span"
          ]
        }
      }
    },
    {
      "fact": {
        "drug_name": "mindfulness-based cognitive therapy",
        "condition_name": "major depressive disorder",
        "relation": "MAINTENANCE_FOR",
        "outcome": null,
        "side_effects": [],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "WJCC",
        "section": "Overview of psychotherapy in depression",
        "span": "After remission, CBT, PEI, and mindfulness-based cognitive therapy (MBCT) are proposed to maintain and prevent depression.",
        "confidence": 0.8,
        "treatment_line": null,
        "patient_subgroup": null,
        "study_design": null,
        "sample_size": null,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "quality_score": 90.0,
      "likely_correct": true,
      "method_results": {
        "heuristic": {
          "quality_score": 90,
          "likely_correct": true,
          "issues": [
            "Condition not explicitly mentioned in span"
          ]
        }
      }
    },
    {
      "fact": {
        "drug_name": "acceptance and commitment therapy",
        "condition_name": "major depressive disorder",
        "relation": "PREVENTS_RELAPSE_IN",
        "outcome": null,
        "side_effects": [],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "WJCC",
        "section": "Structured psychotherapies",
        "span": "Acceptance and commitment therapy is another form of CBT. This type of therapy, which is based on functional contextualism, can help patients accept and adjusting to persistent problems. It appears to be effective in reducing depressive symptoms and preventing relapses.",
        "confidence": 0.8,
        "treatment_line": null,
        "patient_subgroup": null,
        "study_design": null,
        "sample_size": null,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "quality_score": 100.0,
      "likely_correct": true,
      "method_results": {
        "heuristic": {
          "quality_score": 100,
          "likely_correct": true,
          "issues": []
        }
      }
    },
    {
      "fact": {
        "drug_name": "psycho-education",
        "condition_name": "depression",
        "relation": "IMPROVES",
        "outcome": "clinical course, treatment adherence, psychosocial functioning",
        "side_effects": [],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "WJCC",
        "section": "Other psycho-interventions",
        "span": "Many studies have highlighted the role of psycho-education in improving the clinical course, treatment adherence, and psychosocial functioning in patients with depression.",
        "confidence": 0.8,
        "treatment_line": null,
        "patient_subgroup": null,
        "study_design": null,
        "sample_size": null,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "quality_score": 80.0,
      "likely_correct": true,
      "method_results": {
        "heuristic": {
          "quality_score": 80,
          "likely_correct": true,
          "issues": [
            "Span doesn't contain typical IMPROVES language"
          ]
        }
      }
    },
    {
      "fact": {
        "drug_name": "ECT",
        "condition_name": "resistant depression",
        "relation": "EFFECTIVE_IN_SUBGROUP",
        "outcome": null,
        "side_effects": [],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "WJCC",
        "section": "SOMATIC TREATMENTS",
        "span": "ECT is the most well-known treatment for resistant depression, and solid evidence supports its effectiveness and safety.",
        "confidence": 0.9,
        "treatment_line": null,
        "patient_subgroup": null,
        "study_design": null,
        "sample_size": null,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "quality_score": 100.0,
      "likely_correct": true,
      "method_results": {
        "heuristic": {
          "quality_score": 100,
          "likely_correct": true,
          "issues": []
        }
      }
    },
    {
      "fact": {
        "drug_name": "repetitive transcranial magnetic stimulation",
        "condition_name": "depression",
        "relation": "TREATS",
        "outcome": null,
        "side_effects": [],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "WJCC",
        "section": "SOMATIC TREATMENTS",
        "span": "In recent decades, various innovative techniques have been proposed, such as repetitive transcranial magnetic stimulation (rTMS), transcranial direct current stimulation (tDCS), vagus nerve stimulation (VNS), deep brain stimulation (DBS), and magnetic seizure therapy, with varying efficiency levels.",
        "confidence": 0.7,
        "treatment_line": null,
        "patient_subgroup": null,
        "study_design": null,
        "sample_size": null,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "quality_score": 90.0,
      "likely_correct": true,
      "method_results": {
        "heuristic": {
          "quality_score": 90,
          "likely_correct": true,
          "issues": [
            "Condition not explicitly mentioned in span"
          ]
        }
      }
    },
    {
      "fact": {
        "drug_name": "transcranial direct current stimulation",
        "condition_name": "depression",
        "relation": "TREATS",
        "outcome": null,
        "side_effects": [],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "WJCC",
        "section": "SOMATIC TREATMENTS",
        "span": "In recent decades, various innovative techniques have been proposed, such as repetitive transcranial magnetic stimulation (rTMS), transcranial direct current stimulation (tDCS), vagus nerve stimulation (VNS), deep brain stimulation (DBS), and magnetic seizure therapy, with varying efficiency levels.",
        "confidence": 0.7,
        "treatment_line": null,
        "patient_subgroup": null,
        "study_design": null,
        "sample_size": null,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "quality_score": 90.0,
      "likely_correct": true,
      "method_results": {
        "heuristic": {
          "quality_score": 90,
          "likely_correct": true,
          "issues": [
            "Condition not explicitly mentioned in span"
          ]
        }
      }
    },
    {
      "fact": {
        "drug_name": "vagus nerve stimulation",
        "condition_name": "depression",
        "relation": "TREATS",
        "outcome": null,
        "side_effects": [],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "WJCC",
        "section": "SOMATIC TREATMENTS",
        "span": "In recent decades, various innovative techniques have been proposed, such as repetitive transcranial magnetic stimulation (rTMS), transcranial direct current stimulation (tDCS), vagus nerve stimulation (VNS), deep brain stimulation (DBS), and magnetic seizure therapy, with varying efficiency levels.",
        "confidence": 0.7,
        "treatment_line": null,
        "patient_subgroup": null,
        "study_design": null,
        "sample_size": null,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "quality_score": 90.0,
      "likely_correct": true,
      "method_results": {
        "heuristic": {
          "quality_score": 90,
          "likely_correct": true,
          "issues": [
            "Condition not explicitly mentioned in span"
          ]
        }
      }
    },
    {
      "fact": {
        "drug_name": "deep brain stimulation",
        "condition_name": "depression",
        "relation": "TREATS",
        "outcome": null,
        "side_effects": [],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "WJCC",
        "section": "SOMATIC TREATMENTS",
        "span": "In recent decades, various innovative techniques have been proposed, such as repetitive transcranial magnetic stimulation (rTMS), transcranial direct current stimulation (tDCS), vagus nerve stimulation (VNS), deep brain stimulation (DBS), and magnetic seizure therapy, with varying efficiency levels.",
        "confidence": 0.7,
        "treatment_line": null,
        "patient_subgroup": null,
        "study_design": null,
        "sample_size": null,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "quality_score": 90.0,
      "likely_correct": true,
      "method_results": {
        "heuristic": {
          "quality_score": 90,
          "likely_correct": true,
          "issues": [
            "Condition not explicitly mentioned in span"
          ]
        }
      }
    },
    {
      "fact": {
        "drug_name": "magnetic seizure therapy",
        "condition_name": "depression",
        "relation": "TREATS",
        "outcome": null,
        "side_effects": [],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "WJCC",
        "section": "SOMATIC TREATMENTS",
        "span": "In recent decades, various innovative techniques have been proposed, such as repetitive transcranial magnetic stimulation (rTMS), transcranial direct current stimulation (tDCS), vagus nerve stimulation (VNS), deep brain stimulation (DBS), and magnetic seizure therapy, with varying efficiency levels.",
        "confidence": 0.7,
        "treatment_line": null,
        "patient_subgroup": null,
        "study_design": null,
        "sample_size": null,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "quality_score": 90.0,
      "likely_correct": true,
      "method_results": {
        "heuristic": {
          "quality_score": 90,
          "likely_correct": true,
          "issues": [
            "Condition not explicitly mentioned in span"
          ]
        }
      }
    },
    {
      "fact": {
        "drug_name": "ECT",
        "condition_name": "major unipolar depression",
        "relation": "SUPERIOR_TO",
        "outcome": null,
        "side_effects": [],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "WJCC",
        "section": "ECT",
        "span": "ECT is arguably the most effective treatment modality in psychiatry, and its superiority over pharmacotherapy for major unipolar depression is widely supported.",
        "confidence": 0.9,
        "treatment_line": null,
        "patient_subgroup": null,
        "study_design": null,
        "sample_size": null,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "quality_score": 100.0,
      "likely_correct": true,
      "method_results": {
        "heuristic": {
          "quality_score": 100,
          "likely_correct": true,
          "issues": []
        }
      }
    },
    {
      "fact": {
        "drug_name": "rTMS",
        "condition_name": "depression",
        "relation": "IMPROVES",
        "outcome": null,
        "side_effects": [],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "WJCC",
        "section": "rTMS",
        "span": "Recent literature shows a significant difference between rTMS and fictitious stimulation regarding its improvements in depressive symptoms.",
        "confidence": 0.9,
        "treatment_line": null,
        "patient_subgroup": null,
        "study_design": "controlled",
        "sample_size": null,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "quality_score": 90.0,
      "likely_correct": true,
      "method_results": {
        "heuristic": {
          "quality_score": 90,
          "likely_correct": true,
          "issues": [
            "Condition not explicitly mentioned in span"
          ]
        }
      }
    },
    {
      "fact": {
        "drug_name": "rTMS",
        "condition_name": "depression",
        "relation": "AUGMENTS",
        "outcome": null,
        "side_effects": [],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "WJCC",
        "section": "rTMS",
        "span": "Treatments combining rTMS and antidepressants are significantly more effective than placebo conditions, with mild side effects and good acceptability.",
        "confidence": 0.9,
        "treatment_line": null,
        "patient_subgroup": null,
        "study_design": "controlled",
        "sample_size": null,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "quality_score": 90.0,
      "likely_correct": true,
      "method_results": {
        "heuristic": {
          "quality_score": 90,
          "likely_correct": true,
          "issues": [
            "Condition not explicitly mentioned in span"
          ]
        }
      }
    },
    {
      "fact": {
        "drug_name": "tDCS",
        "condition_name": "unipolar depression",
        "relation": "IMPROVES",
        "outcome": "response and remission rate",
        "side_effects": [],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "WJCC",
        "section": "tDCS",
        "span": "The tDCS technique significantly outperforms the simulator in terms of the rate of response and remission. It can be used as a complementary intervention or as monotherapy to reduce depressive symptoms in unipolar or bipolar depression patients.",
        "confidence": 0.9,
        "treatment_line": null,
        "patient_subgroup": null,
        "study_design": null,
        "sample_size": null,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "quality_score": 100.0,
      "likely_correct": true,
      "method_results": {
        "heuristic": {
          "quality_score": 100,
          "likely_correct": true,
          "issues": []
        }
      }
    },
    {
      "fact": {
        "drug_name": "tDCS",
        "condition_name": "bipolar depression",
        "relation": "IMPROVES",
        "outcome": "response and remission rate",
        "side_effects": [],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "WJCC",
        "section": "tDCS",
        "span": "The tDCS technique significantly outperforms the simulator in terms of the rate of response and remission. It can be used as a complementary intervention or as monotherapy to reduce depressive symptoms in unipolar or bipolar depression patients.",
        "confidence": 0.9,
        "treatment_line": null,
        "patient_subgroup": null,
        "study_design": null,
        "sample_size": null,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "quality_score": 100.0,
      "likely_correct": true,
      "method_results": {
        "heuristic": {
          "quality_score": 100,
          "likely_correct": true,
          "issues": []
        }
      }
    },
    {
      "fact": {
        "drug_name": "VNS",
        "condition_name": "resistant depression",
        "relation": "TREATS",
        "outcome": null,
        "side_effects": [],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "WJCC",
        "section": "VNS",
        "span": "VNS is a therapeutic method that has been used for the last sixteen years to treat resistant unilateral or bipolar depression. However, despite several clinical studies attesting to its favorable benefit-risk ratio and its approval by the Food Drug Administration in 2005, it is not used very often.",
        "confidence": 0.8,
        "treatment_line": null,
        "patient_subgroup": null,
        "study_design": "clinical studies",
        "sample_size": null,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "quality_score": 100.0,
      "likely_correct": true,
      "method_results": {
        "heuristic": {
          "quality_score": 100,
          "likely_correct": true,
          "issues": []
        }
      }
    },
    {
      "fact": {
        "drug_name": "VNS",
        "condition_name": "resistant depression",
        "relation": "EFFECTIVE_IN_SUBGROUP",
        "outcome": null,
        "side_effects": [],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "WJCC",
        "section": "VNS",
        "span": "Since the turn of the century, numerous studies have demonstrated the efficacy of VNS in resistant depression.",
        "confidence": 0.8,
        "treatment_line": null,
        "patient_subgroup": null,
        "study_design": "numerous studies",
        "sample_size": null,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "quality_score": 100.0,
      "likely_correct": true,
      "method_results": {
        "heuristic": {
          "quality_score": 100,
          "likely_correct": true,
          "issues": []
        }
      }
    },
    {
      "fact": {
        "drug_name": "VNS",
        "condition_name": "resistant depression",
        "relation": "IMPROVES",
        "outcome": "depressive symptoms",
        "side_effects": [],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "WJCC",
        "section": "VNS",
        "span": "VNS has demonstrated progressively increasing improvements in depressive symptoms, with significant positive outcomes observed after six to 12 mo; these benefits can last for up to two years.",
        "confidence": 0.8,
        "treatment_line": null,
        "patient_subgroup": null,
        "study_design": null,
        "sample_size": null,
        "duration": "6 to 12 months",
        "dose": null,
        "p_value": null
      },
      "quality_score": 90.0,
      "likely_correct": true,
      "method_results": {
        "heuristic": {
          "quality_score": 90,
          "likely_correct": true,
          "issues": [
            "Condition not explicitly mentioned in span"
          ]
        }
      }
    },
    {
      "fact": {
        "drug_name": "rTMS",
        "condition_name": "depression",
        "relation": "WELL_TOLERATED_IN",
        "outcome": null,
        "side_effects": [],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "WJCC",
        "section": "Luxtherapy (phototherapy)",
        "span": "rTMS is an interesting technique as well, as it offers a well-tolerated profile.",
        "confidence": 0.8,
        "treatment_line": null,
        "patient_subgroup": null,
        "study_design": null,
        "sample_size": null,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "quality_score": 90.0,
      "likely_correct": true,
      "method_results": {
        "heuristic": {
          "quality_score": 90,
          "likely_correct": true,
          "issues": [
            "Condition not explicitly mentioned in span"
          ]
        }
      }
    },
    {
      "fact": {
        "drug_name": "ECT",
        "condition_name": "depression",
        "relation": "TREATS",
        "outcome": null,
        "side_effects": [],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "WJCC",
        "section": "discussion",
        "span": "ECT is the only somatic treatment with confirmed indications for certain forms of depression.",
        "confidence": 0.8,
        "treatment_line": null,
        "patient_subgroup": null,
        "study_design": null,
        "sample_size": null,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "quality_score": 100.0,
      "likely_correct": true,
      "method_results": {
        "heuristic": {
          "quality_score": 100,
          "likely_correct": true,
          "issues": []
        }
      }
    },
    {
      "fact": {
        "drug_name": "combinations of medications, psychotherapy, and somatic therapies",
        "condition_name": "resistant forms of depression",
        "relation": "EFFECTIVE_IN_SUBGROUP",
        "outcome": null,
        "side_effects": [],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "WJCC",
        "section": "discussion",
        "span": "Combinations of medications, psychotherapy, and somatic therapies remain the most effective ways to manage resistant forms of depression.",
        "confidence": 0.8,
        "treatment_line": null,
        "patient_subgroup": null,
        "study_design": null,
        "sample_size": null,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "quality_score": 100.0,
      "likely_correct": true,
      "method_results": {
        "heuristic": {
          "quality_score": 100,
          "likely_correct": true,
          "issues": []
        }
      }
    }
  ]
}